Tirzepatide (Mounjaro) has been recommended by NICE for the treatment of type 2 diabetes in adults (NICE TA924) and has also been assessed in the context of weight management
Strategies to mitigate muscle loss Muscle talks to your gut during exercise: Physical activity triggers muscle release of IL-6 and other signals that actually boost GLP-1 production in the intestines, creating a natural feedback loop that supports metabolism
Data analysed by two-way repeated measures ANOVA to assess main effect effects of treatment ( b , c , f , g , j , k and m ) and two-way ANOVA, multiple comparison, Bonferroni post hoc test ( h )
The cardiac drug therapy included acetylsalicylic acid, apixaban, furosemide, and metoprolol
As an oral GLP-1 therapy, it gives Lilly a way to reach patients who may not want Zepbound or other injectable options
Increase the dose every 4 weeks, by 2 mg increments, until the desired weight loss results are achieved